The effect of PI3K inhibition on the growth and survival of HNSCC cells was investigated with the pan-PI3K inhibitor BKM120 and the dual PI3K and mTOR inhibitor GDC0980 by a short-term survival assay and colony assay (Fig. 1A,B). This evidence concerns the gene MTOR and head and neck squamous cell carcinoma.